Speakers
Liang Bao
Founder and CEO
ChemShuttle
Joshua Berlin
Head of Corporate Alliances & Business Development
BioCentury Inc.
Harm-Jan Borgeld, Ph.D.
Global Head, Asia Partnering
Roche
Patrick Branch
Head of Business Development, Japan & APAC
Nxera Pharma
Wei William Cao, Ph.D.
Founder & Former CEO
Gracell Biotechnologies, AstraZeneca
Li Chen, Ph.D.
CEO & Executive Director
Hua Medicine Ltd.
Yan Chen, Ph.D.
Founder, President & CEO
Elpis Biopharmaceuticals
David Chen
Partner
Goodwin
Rulei Chen
Co-Founder & COO
Innolake Biopharm Co. Ltd.
Jeff Cranmer
Executive Editor and Head of Daily Global Intelligence
BioCentury Inc.
Can Cui, PhD, JD
Partner
Goodwin
Tim Ding
General Manager
Veeva China
Ronnie Ede
Executive Director, Fund Managing Partner
Innovent
David Flores
Co-Founder, President & CEO
BioCentury Inc.
Sean He
Partner & Head of China
Novo Holdings
Josh Hofheimer
Partner & Co-Head of Global Life Sciences Group
Sidley
Zhi Hong, Ph.D.
Chairman & CEO
Brii Bioscience
James Huang
Managing Partner
Panacea Venture
Cherry Huang
President, China
Johnson & Johnson Innovative Medicine
Zhaoyu JIN, Ph.D.
Founder & CEO
FutureGen Biopharmaceutical
Vijay Karwal
Managing Director
CBC Group
Paul Koolenbrander
CEO
Rxilient Health
Franck Le Deu
Senior Partner & Co-Leader of Asia Life Sciences Practice
McKinsey & Company
Leo Lee
President & Managing Director, China
Novartis
Daniel Lee, M.D.
Senior Associate
Blackstone
Jeremy Levin (林伟峻) D.Phil, MB BChir
Former Chair, Biotechnology Innovation Organization (BIO) and
Chairman and CEO of Ovid Therapeutics
Jeremy Levin, D.Phil, MB BChir
Former Chair, Biotechnology Innovation Organization (BIO) and
Chairman and CEO of Ovid Therapeutics
Bin Li, Ph.D.
Founder, CEO & Chief Investment Officer
Lake Bleu Capital
Xiang Li (Michael Lee), Ph.D.
Founder & CEO
XellSmart
Zili Li, M.D. M.D., MPH
Fellow, Drug Information Association, and former VP & Head of Asia Pacific R&D
Johnson & Johnson
James C. Lin, D.Phil.
Partner
Davis Polk
Da Liu
Managing Director
CR-CP Life Science Fund
Dan Liu, Ph.D.
Managing Partner
Pivotal bioVenture Partners
Lois Sheng Liu
Associate
Baker & McKenzie
Yiming Liu
Partner in Charge, Shanghai
Cooley
Wendy Pan, Ph.D.
Partner & Leader of Asia Life Sciences, Goodwin and
Chairwoman, BayHelix
Jason Peng
Partner
McKinsey & Company
Jean-Christophe Pointeau
President, China
Pfizer Inc.
Fei Qi, Ph.D.
Executive Director
Legend Capital
Maha Radhakrishnan, M.D.
Executive Partner
Sofinnova Investments
Albert Ren, Ph.D.
VP, Strategy & Business Development, China
Pfizer
Yibing Shan
Founding Managing Director
AB Magnitude Ventures
Joan Shen, M.D., Ph.D.
Founder & CEO
NeuShen Therapeutics
David Shen, Ph.D.
Founder & CEO
Proteologix
Stella Shi
Founder & CEO
RONA Therapeutics
Yong-Hui Shi, Ph.D.
SVP, Chief Strategy and Corporate Development Officer
MicroTech Medical
Lei Shi, Ph.D.
Partner
Eight Roads Ventures
Wayne Shi
President, Greater China
Sanofi
Victor Shi, Ph.D.
former Chairman, BayHelix, and
Managing Partner, Serica Partners
Dongxu Shu, Ph.D.
Founder & CEO
Argo Biopharma
Randall Sunberg
Partner
Baker & McKenzie
Xin Tao
Partner & Chair, U.S. FDA Practice
Baker & McKenzie
Jody Tian
Partner
McKinsey & Co.
Sam Waksal, Ph.D.
Chairman & CEO
Graviton Bioscience
Bing Wang, Ph.D.
CFO
Akeso Biopharma
Jin Wang
Senior Partner, Leader of China Healthcare Practice
McKinsey & Co.
Xuelin (Steve) Wang
Partner
Davis Polk
Jerry Wang
President of Greater China
Siemens Healthineers
Zhenghui (Alan) Wang, Ph.D.
Partner
Goodwin
Cynthia Wang
Director, Business Development, Asia-Pacific
Servier
Chengbin Wu, Ph.D.
Founder and CEO
EpimAb Biotherapeutics
Jie Wu
Head, APAC
MPM BioImpact
Xiaobin WU, Ph.D.
President & Chief Operating Officer
BeiGene Ltd.
Sean Wu
Senior Research Analyst
Morgan Stanley
Josie Xi Zhou, PH.D.
Partner
McKinsey & Company
Megan Xu
Director, Search & Evaluation,
Novartis
Stella Xu, Ph.D.
Managing Partner
Quan Capital
Jing Xu, Ph.D.
Principal
LYFE Capital
Jenny Yang, Ph.D.
Senior Director, Global Search & Evaluation
Novo Nordisk
Chen Yang
Partner
Sidley Austin
Yuan Yuan, Ph.D.,
Principal
Eight Roads Ventures
Dan Zhang, M.D.
Co-Chairman
Hillgene
Hua ZHANG
VP, Head of Science and Regulatory Affairs
RDPAC
Hong Zhang
Partner
Baker & McKenzie
Alex J. Zhang
CEO
OneTwenty Therapeutics Inc.
Jimmy Zhang, Ph.D.
Former Chairman, BayHelix, and Head of Business Development
Frontier Biotechnologies
John Zhu, Ph.D.
Founder & CEO
Duality Biologics
Jieyu Zou
Partner
Lilly Asia Ventures
Past China Healthcare Summit Speakers
Click below to see the 2023 full list of Speakers.